A special subset of T cells, MAIT cells that are present in MS lesions and are preferentially recruited into the CNS during exacerbations produce higher IL-17 in MS compared to healthy controls, and their decline in the peripheral blood coincided with Gd-enhancing lesions [58,59]. This evidence concerns the gene IL17A and myeloid sarcoma.